… with coronavirus disease 2019 (COVID-19) receiving corticosteroids. This study evaluated
the efficacy and safety of sarilumab, … , in the treatment of hospitalized patients with COVID-19. …

… the treatment of COVID-19. We aim to assess the role of sarilumab in the treatment of COVID-19
… , but there were no significant differences among the comparison and sarilumab group. …

… of SARS-CoV-2 related acute respiratory distress syndrome (ARDS) and MOD, we reviewed
the current evidence regarding the safety and efficacy of the sarilumab administration in the …

… It is a safe and well-tolerated drug.8 The most common … safety of early treatment with
sarilumab added to standard treatment to prevent progression to severe pulmonary forms of COVID…

… coronavirus disease 2019 (COVID-19). High Interleukin-6 (IL6) blood levels have been identified
in severe COVID-19 disease… support the safety of the use of sarilumab in this indication. …

… safety of early treatment with sarilumab, added to standard of care (SOC), in hospitalized
adults with COVID… trial of hospitalized patients with COVID-19 pneumonia and interleukin (IL)-6 …

… COVID-19 patients. We analyzed DILI cases associated with tocilizumab or sarilumab in
treating COVID-… Disproportionality analysis and Bayesian analysis of COVID-19 patients were …

… This study investigated the efficacy and safety of interleukin-6 (IL-6) receptor antagonists
with standard care treatment in patients with coronavirus disease 2019 (COVID-19). The …

… trial, we systematically collected all SAEs and AESIs providing important safety information
of the use of sarilumab of doses up to 800 mg in the hospitalized Covid-19 population. …

… In summary, sarilumab is a safe drug with good clinical outcomes in patients with COVID-19 …
assess the efficacy and safety of this therapeutic approach to achieve improved outcomes in …